Share Price:

APNASPENAspen Pharmacare Hldgs102500 (0.00%)

Statement in response to The Times of London report on 20 May 2017 on Florinef

Having noted the report published in The Times of London on 20 May 2017 titled โ€œMassive price rise for vital drug put petsโ€™ lives at riskโ€, Aspen wishes to express its disappointment and concern that much of the information and clarification it provided to The Timesโ€™ Billy Kenber prior to the report being published has… Continue reading Statement in response to The Times of London report on 20 May 2017 on Florinef

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.